Orthosera’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

OrthoSera is an ortho biologics company that develops serum-based solutions for musculoskeletal indications. Read more

OrthoSera is an ortho biologics company that develops serum-based solutions for musculoskeletal indications. Read more

Zsombor Lacza's photo - Founder & CEO of Orthosera

Founder & CEO

Zsombor Lacza

CEO Approval Rating

70/100

Founded:

2012

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees
Sector

Update Industry

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $ < 1M a good estimate for Orthosera's revenue?

Acquisitions

No recent acquisitions found related to Orthosera

Orthosera Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series B
Feb 2017
--

Euroventures Capital Advisory

Equity
Dec 2015
--

Since Orthosera was founded in 2012, it has participated in 2 rounds of funding. In total Orthosera has raised $0. Orthosera's last funding round was on Feb 2017 for a total of $0

Investments

No recent investments found related to Orthosera

Orthosera News

November 29, 2017BioPortfolio

Orthosera GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09112017 Prices from USD $250

SummaryOrthosera GmbH OrthoSera formerly Lacerta Technologies GmbH is a regenerative medicine company... See more »
May 25, 2017BioPortfolio

Orthosera GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Updated 12052017 Prices from USD $250

SummaryOrthosera GmbH OrthoSera formerly Lacerta Technologies GmbH is a regenerative medicine company... See more »
April 11, 2017BioPortfolio

Orthosera GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Updated 23032017 Prices from USD $250

SummaryOrthosera GmbH OrthoSera formerly Lacerta Technologies GmbH is a regenerative medicine company... See more »
February 9, 2017BioSpace

OrthoSera Closes Series B Financing Round

Life Sciences Jobs ...... See more »
September 6, 2016MassDevice

OrthoSera wins CE Mark for hypACT regenerative osteoarthritis device

Orthobiologics company OrthoSera GmbH said today it won CE Mark approval in the European Union for it... See more »
December 15, 2015BioSpace

<b>OrthoSera</b> Successfully Closes Financing Round And Appoints Advisory Board

Investment syndicate led by EuroventuresFunding for additional product launch in 2016Krems an der Don... See more »

Orthosera Press Releases

Social Media

Headquarters

Dr. Karl-Dorrek-Straße 23-29

Krems an der Donau, Lower Austria3500

43-664-883-16206

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

OrthoSera is an ortho biologics company that develops serum-based solutions for musculoskeletal indications. Orthosera was founded in 2012. Orthosera's headquarters is located in Krems an der Donau, Lower Austria, AT 3500. It has raised undisclosed am...

CEO

Orthosera's Founder & CEO, Zsombor Lacza, currently has an approval rating of 70%. Orthosera's primary competitors are

Website

orthosera.com

Frequently Asked Questions about Orthosera

  1. When was Orthosera founded?

    Orthosera was founded in 2012
  2. Who is Orthosera's CEO?

    Orthosera's CEO is Zsombor Lacza
  3. How much revenue does Orthosera generate?

    Orthosera generates $ < 1M in revenue
  1. How much funding does Orthosera have?

    Orthosera has historically raised $0 in funding
  2. Where is Orthosera's headquarters?

    Orthosera's headquarters is in Krems an der Donau Lower Austria, AT
  3. How many employees does Orthosera have?

    Orthosera has 0 employees